InsiderTrades

Form 4 for SLDB Solid Biosciences Inc.

Accepted 2024-12-04 00:00:00 ET · period of report 2024-12-02 · accession 0000950170-24-133317 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-12-04 2024-12-03 SLDB Herzich Paul CTO S - Sale+OE $5.60 -2,777 12.2K -19% -$15.6K
D 2024-12-04 2024-12-02 SLDB Herzich Paul CTO M - OptEx — +7,239 15.0K +94% —
D 2024-12-04 2024-12-02 SLDB Herzich Paul CTO M - OptEx $0.00 -7,239 14.5K -33% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-12-03 S D 2,777 $5.60 12,182 D — — (F3) This sale was made to cover withholding taxes following the vesting of the previously granted RSUs. The sale does not represent a discretionary trade made by Dr. Herzich.
2 Common Common Stock 2024-12-02 M A 7,239 — 14,959 D — — (F1) Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the "RSUs"). (F2) Includes 1,698 shares of common stock acquired under the Solid Biosciences Inc. Employee Stock Purchase Plan on May 31, 2024.
3 Derivative Restricted Stock Units 2024-12-02 M D 7,239 $0.00 14,478 D — · — to — 7,239 Common Stock (F1) Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the "RSUs"). (F4) The RSUs were granted on December 2, 2022 (the "Grant Date") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary.